Impacts and effects of COVID-19 infection in pregnancy

Sunder, Amala; Varghese, Bessy; Darwish, Basma; Shaikho, Noor; Rashid, Mooza

doi:10.15537/smj.2022.43.1.20210694

Cited by 13 publications

(10 citation statements)

References 28 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The increase in uterine artery PI values may be useful in predicting the patients to be followed in terms of preeclampsia and FGR risk in pregnant individuals who had COVID‐19. In another study investigating the effects of COVID‐19 infection on pregnancy ( n = 74), it was found that the incidence of fetal growth restriction is higher in pregnant women who have had this infection ( p < 0.001) 20 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Assessment of fetal myocardial performance index in pregnant women with SARS‐CoV‐2 infection: A prospective cohort study

Kahramanoğlu,

Akalin,

Bilir

et al. 2023

J of Clinical Ultrasound

View full text Add to dashboard Cite

ObjectivesOur aim was to investigate the effects of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection on fetal myocardial performance in women who had it during their pregnancy.Materials and MethodsIn our prospective cohort study including healthy pregnant women and pregnant with SARS‐CoV‐2 infection, we collected patients' data between June 2021 and April 2022. Maternal characteristics, gestational age at SARS‐CoV‐2 infection and ultrasound examination, and body mass index were noted. Fetal biometry, fetal anatomy scanning, placenta, amniotic fluid index (AFI), and Doppler parameters were routinely examined in all patients. Left ventricular myocardial performance index (MPI) was measured during fetal echocardiography examination. Doppler parameters, AFI, and MPI values were compared between two groups.ResultsCompared with the control group (n = 80), MPI values were found within normal limits in fetuses of pregnant women with SARS‐CoV‐2 infection (n = 80) (MPI: 0.38 ± 0.06 in the control groups vs. 0.39 ± 0.05 in the SARS‐COV‐2 positive group, p = 0.79). There was no relationship between SARS‐CoV‐2 infection and changes in AFI and umbilical artery pulsatility index (PI) values. Uterine artery PI values were significantly higher in pregnant women with (SARS‐CoV‐2) infection (0.81 in the control group vs. 0.97 in the SARS‐CoV‐2 group, p < 0.05).ConclusionsFetal cardiac functions were not affected in pregnant women with previous (SARS‐CoV‐2) infection. Further metaanalyses are warranted to confirm the results.

show abstract

Section: Discussionmentioning

confidence: 99%

“…In another study investigating the effects of COVID-19 infection on pregnancy (n = 74), it was found that the incidence of fetal growth restriction is higher in pregnant women who have had this infection ( p < 0.001). 20 COVID-19 infection can cause myocarditis. 21,22 It has been…”

Section: Discussionmentioning

confidence: 99%

Assessment of fetal myocardial performance index in pregnant women with SARS‐CoV‐2 infection: A prospective cohort study

Kahramanoğlu,

Akalin,

Bilir

et al. 2023

J of Clinical Ultrasound

View full text Add to dashboard Cite

show abstract

“…In the study of Wei et al, 12 there is a relationship between COVID‐19 and low birth weight, as in our study. According to Sunder et al, COVID‐19 increases the risk of fetal growth restriction 24 …”

Section: Discussionmentioning

confidence: 99%

“…According to Sunder et al, COVID-19 increases the risk of fetal growth restriction. 24 Khalil et al detected an increase in the incidence of stillbirth during the COVID-19 pandemic. 25 In the study of Mor et al, although it was observed that the stillbirth rate increased in COVID-19 disease, no relationship was found between intrapartum fetal death rate and COVID-19 disease.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the effects of COVID‐19 disease and the trimester in which the disease is diagnosed on obstetric and neonatal outcomes: A retrospective cohort study

Sertel¹,

Demir

2022

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim: To evaluate the effects of COVID-19 disease and the trimester in which the disease is diagnosed on obstetric and neonatal outcomes. Methods: This retrospective cohort study was conducted with 358 patients who had or had not been diagnosed with COVID-19 during their pregnancy, had a miscarriage or had given birth. Results: COVID-19 disease during pregnancy was associated with higher maternal hypertensive disease, preterm birth, low birth weight, low firstand fifth-minute Apgar scores, and need for neonatal intensive care unit. The incidence of preterm birth, low birth weight, low firstand fifth-minute Apgar scores, and need for neonatal intensive care unit in those diagnosed with COVID-19 in the second trimester was significantly higher than those diagnosed with COVID-19 in other trimesters. The frequency of cesarean section was observed most in those diagnosed with COVID-19 in the 3rd trimester, while it was observed in those diagnosed with COVID-19 at least in the first trimester. Conclusion:The presence of COVID-19 during pregnancy may be associated with an increased risk of iatrogenic preterm birth. The frequency of preterm birth in pregnant women diagnosed with COVID-19 in the second trimester is higher than in pregnant women diagnosed with COVID-19 in other trimesters. As the pregnancy trimester at the time of diagnosis progresses, the frequency of cesarean section increases. While the risk of maternal hypertensive disease increases more in pregnant women with COVID-19, the effect of the trimester in which COVID-19 was passed on the risk of maternal hypertensive disease is not observed.

show abstract

“…The complications by trimester of pregnancy were statistically significant for miscarriage where 25%–26% reported in the 1st trimester, 40% in the second, and 0% in the third one. No vertical transmission was observed ( Sunder et al, 2022 ). In the Sultanate of Oman, it was shown that the risk of ICU admission, preterm labor, pre-eclampsia, and emergency lower segment C-section, in addition to thromboembolic complications, are increased in pregnant women with COVID-19.…”

Section: Pregnant Women and Neonatesmentioning

confidence: 99%

Prognosis of COVID-19 in the middle eastern population, knowns and unknowns

Dandachi

Aljabr

2022

Front. Microbiol.

View full text Add to dashboard Cite

Since its emergence in China in 2019, the SARS-CoV-2 virus has affected all countries worldwide. The virus is easily transmitted from one person to another via infected aerosols or contaminated surfaces. Unlike its counterparts, the prognosis of COVID-19 ranges from asymptomatic to critical disease or death. Several factors play a role in determining the severity of the disease in infected patients. Among others, is the pre-existence of an underlying medical condition such as diabetes, cancer, and others. Furthermore, although children are less prone to the severe form of the COVID-19 disease, they require attention due to the report of many atypical presentations of the infection, post-asymptomatic exposure. In the Middle East, little is known about the prognosis of the SARS-CoV-2 infection in high-risk categories, notably patients with diabetes, cancer, and pregnant women. The aim of this review is to summarize the current knowledge about this group of population in the middle eastern region as well as to highlight the gap in the literature. We have found that the majority of the papers were from the Gulf countries. Although, few studies were conducted; high-risk patients appear to have an increased risk of morbidity and mortality from COVID-19 compared to their counterparts. Higher levels of inflammatory markers, C-reactive protein, erythrocyte sedimentation rate, D-dimer, and ferritin levels were also observed. Children are often asymptomatic or present with atypical presentations. More studies should be conducted to determine the clinical biomarkers of COVID-19 in high-risk categories to help in patient risk stratification and management in the middle eastern population.

show abstract

Impacts and effects of COVID-19 infection in pregnancy

Abstract: Objectives: To explore the trimester wise significance of the primary outcome in pregnant women during coronavirus disease-19 (COVID-19) pandemic.

Cited by 13 publications

References 28 publications

Assessment of fetal myocardial performance index in pregnant women with SARS‐CoV‐2 infection: A prospective cohort study

Assessment of fetal myocardial performance index in pregnant women with SARS‐CoV‐2 infection: A prospective cohort study

Evaluation of the effects of COVID‐19 disease and the trimester in which the disease is diagnosed on obstetric and neonatal outcomes: A retrospective cohort study

Prognosis of COVID-19 in the middle eastern population, knowns and unknowns

Contact Info

Product

Resources

About